Premium
Breast‐Cancer Diagnosis by Neuropeptide Y Analogues: From Synthesis to Clinical Application
Author(s) -
Khan Irfan U.,
Zwanziger Denise,
Böhme Ilka,
Javed Muhammad,
Naseer Hamid,
Hyder Syed W.,
BeckSickinger Annette G.
Publication year - 2010
Publication title -
angewandte chemie international edition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.831
H-Index - 550
eISSN - 1521-3773
pISSN - 1433-7851
DOI - 10.1002/anie.200905008
Subject(s) - neuropeptide y receptor , breast cancer , cancer , neuropeptide , receptor , cancer research , transduction (biophysics) , peptide , chemistry , medicine , computational biology , endocrinology , biology , biochemistry
Selective, sensitive, and specific breast cancer diagnosis : Neuropeptide Y (NPY) and the Y 1 R‐selective [Phe 7 , Pro 34 ]NPY peptide were labeled with Re/ 99m Tc and pre‐clinically characterized using competition receptor binding and signal transduction assays, and also microscopic, metabolic‐stability, rabbit body‐uptake, and protein‐binding studies. Selective uptake of the 99m Tc(core) 3+ ‐(N α His‐ac)‐labeled [Phe 7 , Pro 34 ]NPY analogue in human breast‐cancer patients was obtained by whole body scintimammography.